GlycoErase™ UGT3A1 Knockout Glycoengineered Cell (CAT#: GLJF-0825-JF153)

Description	GlycoErase™ UGT3A1 knockout glycoengineered cell disrupts UDP-glucuronosyltransferase 3A1, part of the GlcNAc transferase complex contributing to glycosylation. This model supports studies of glycan biosynthesis and glucuronidation.
Product Type	KO Cell Lines
Cell Line	As requested by the client.

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Application	Functional assay
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	UGT3A1
Compounds Targeting	Kaempferol (bone resorption inhibitor, estrogen-related receptor inverse agonist) Quercetin (polar auxin transport inhibitor)
Full Name	UDP glycosyltransferase family 3 member A1
Alternative Name	FLJ34658
Location	5p13.2
Gene ID	133688
Summary	Glucuronosyltransferase that is part of the UDP-N-acetylglucosamine transferase complex, contributing to glycosylation processes.